The short version
Only one company currently supplies this market — there is no backup if it stumbles. It is in shortage right now.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Zanosar
Streptozocin · STREPTOZOCIN 1 g/10mL · Powder, For Solution · Intravenous · Esteve Pharmaceuticals, S.a.
NDC 68118-0100-01 · 1 VIAL, GLASS in 1 CARTON / 10 mL in 1 VIAL, GLASS · UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- —
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- —
Shortage history
- In shortage now — Zanosar, Powder, For Solution, 1 g/10 mL (NDC 68118-100-01)Jul 12, 2022month 50 — 4× the typical 12-month other shortage · model puts 53% odds it resolves within 6 months
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Streptozocin (Powder, For Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Esteve Pharmaceuticals, S.a. | STREPTOZOCIN 1 g/10mL | Jul 15, 2026 | Sep 3, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Zanosar — NDC 68118-0100-01," retrieved September 3, 2026, https://drugdashboards.com/drug/68118010001.
Free to cite with attribution — see how the data is put together.